SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: laleh who wrote (155)11/6/1997 9:44:00 PM
From: Manny Gugliuzza  Read Replies (1) of 1510
 
please check ff. site for insider trading stocksmart.com select sellers
1 month
imnr
most active. sorry to put this response in front of yours ted.

i have enjoyed reading these letters over the past few months. many have been informative,supportive, helpfull as well as entertaining chris, mark, joel,john,robert ,et al thank you.

having some background in the medical field as a veterinarian i have read and understood most of the companys literature involving the therapy and procedures for the major problems they have undertaken to control. i have never taken a course on business and marketing and none were ever offered in vet school. most of my understanding comes from hands on after owning my own practice of 10 yrs and from reading
from others mistakes, and from direct dealings with major drug companies. ciba. merk. bayer. etc. what i feel the company knows, and this is irregardless of insider trading because laleh is right even these 100,000 shares sold inside are probably options which have come due or are allowed to be sold after a certain waiting period, is what we as investors have come to expect. the company has well described these expections an should be read by all at sec.yahoo.com READ THE WHOLE THING

we also use immune stimulants in veterinary medicine for staph positive animals and cats with feline aids and feline leukemia.

the fda is corrupt. merk, bayer and ciba may have more than a combining interest in a 4th add on drug to a failing triple therapy.
immune unfortunetly has to float nearly 80% of its entire stock to cover some of the costs. unless institutional buying cranks this price, one of these gargantuans will swallow this. then that extra 30$ a share above their break even price of 28$ is going to appear as a much smaller increase in a larger companys stock price. does this make any sense? a possible? how about this. i believe that this company is not only going in the absolute right direction in their therapy
against these diseases but they also have the belief of these major drug corporations who can use their influence with the fda and may have already to get these trials running inorder to save their failing
combination therapy. hiv virus is not killing these people it is their immune system that cannot fight off the invader and 2nd infections that take over. support your immune system buy imnr.
AR.
drdarn19@idt.net
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext